Somatostatin Therapy Improves Stellate Cell Activation and Early Fibrogenesis in a Preclinical Model of Extended Major Hepatectomy
Liver resection treats primary and secondary liver tumors, though clinical applicability is limited by the remnant liver mass and quality. Herein, major hepatic resections were performed in pigs to define changes associated with sufficient and insufficient remnants and improve liver-specific outcome...
Main Authors: | Amelia J. Hessheimer, Jordi Vengohechea, Lilia Martínez de la Maza, Javier Muñoz, Marina Vendrell, Josep Martí Sanahuja, Alba Torroella, Farah Adel Al Shwely, Francisco Riquelme, César Muñoz, Rocío García, Pilar Taurá, Constantino Fondevila |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/3989 |
Similar Items
-
Effects of terlipressin and somatostatin on liver function after major hepatectomy for hepatocellular carcinoma
by: Jiangwei Ye, et al.
Published: (2021-07-01) -
Liver Regeneration after Hepatectomy and Partial Liver Transplantation
by: Shintaro Yagi, et al.
Published: (2020-11-01) -
Open versus laparoscopic hepatectomy: 5 years of experience in a third-level hospital
by: Alberto De Anda-Coronado, et al.
Published: (2022-10-01) -
Safety and efficacy of precision hepatectomy in the treatment of primary liver cancer
by: Junhong Zhang, et al.
Published: (2023-08-01) -
Significance of predicted future liver remnant volume on liver failure risk after major hepatectomy: a case matched comparative study
by: R. Piccus, et al.
Published: (2023-05-01)